Mohammad Amin Shahrbaf

Mohammad Amin Shahrbaf


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2022 in Cells
Verified
Journal Article
Open access
PDF file
MSMohammad Amin Shahrbaf
Mohammad Amin Shahrbaf
MNMasoumeh Nouri
Masoumeh Nouri
MZMorteza Zarrabi
Morteza Zarrabi
Roberto GramignoliRoberto Gramignoli
Roberto Gramignoli
Massoud VosoughMassoud Vosough
Massoud Vosough
Liver disorders have been increasing globally in recent years. These diseases are associated with high morbidity and mortality rates and impose high care costs on the health system. Acute liver failure, chronic and congenital liver diseases, as well as hepatocellular carcinoma have been limitedly treated by whole organ transplantation so far. But novel treatments for liver disorders using cell-based approaches have emerged in recent years. Extra-embryonic tissues, including umbilical cord, amnion membrane, and chorion plate, contain multipotent stem cells. The pre-sent manuscript discusses potential application of extraembryonic mesenchymal stromal/stem cells, focusing on the management of liver diseases. Extra-embryonic MSC are characterized by robust and constitutive anti-inflammatory and anti-fibrotic properties, indicating as therapeutic agents for inflammatory conditions such as liver fibrosis or advanced cirrhosis, as well as chronic inflammatory settings or deranged immune responses.

5 October 2022 in International Journal of Preventive Medicine
Verified
Journal Article
Open access
MSMohammad Amin Shahrbaf
Mohammad Amin Shahrbaf
DNDanialSamiei Nasr
DanialSamiei Nasr
ZLZoyaTavaf Langroudi
ZoyaTavaf Langroudi